To hear about similar clinical trials, please enter your email below
Trial Title:
Cancer Patient Empowerment Program: Phase 2 Feasibility Study
NCT ID:
NCT05508412
Condition:
Cancer
Study type:
Interventional
Study phase:
N/A
Overall status:
Active, not recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Supportive Care
Masking:
None (Open Label)
Intervention:
Intervention type:
Behavioral
Intervention name:
CancerPEP
Description:
CancerPEP
Arm group label:
Intervention with HRV monitor
Arm group label:
Intervention without HRV monitor
Summary:
The Cancer Patient Empowerment Program is a comprehensive health promotion program aiming
to improve the quality of life as well as both physical and mental health in cancer
patients and survivors. The program includes daily email communications over 6 months
that encourage strength and aerobic exercise, yoga, stress reduction techniques, dietary
improvements, and more.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Age >18.
- History of a cancer diagnosis as per the participant's report.
- Safe to exercise and do strength training. Participants who have recovered from a
minor stroke or heart condition in the past will require approval from their Family
Physician or Cardiologist to participate in the study.
- Participants with advanced cancer (including cancer spread to bones) will need
approval from the Study Physician or their Oncologist to participate.
- Existing (or willingness to create) email account and willingness to access email
daily.
- Ability to follow website links to watch YouTube videos.
- Ability to understand and speak English.
- Ability to participate in low to moderate levels of physical activity and strength
training.
- Ability and willingness to fill out an online survey at baseline, and 6, 12 and
possibly 24 months, and a weekly compliance survey for the six months of the
program.
- Deemed to have an expected survival greater than 1 year and expected to be well
enough to complete the six-month training
Exclusion Criteria:
- Patients deemed unfit to participate in low to moderate level exercise e.g.,
including but not limited to a myocardial infarction or stroke within the last year,
without approval from their Family Physician or Cardiologist that they are safe to
exercise.
- Unable to access the internet and lack of a computer or smartphone to receive emails
required for study intervention, or unable to click on a link to successfully watch
a YouTube video.
- Those with a predicted survival less than 1 year, or not expected to be able to
participate in the program for six months.
Gender:
All
Minimum age:
19 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
QEII Health Sciences Centre
Address:
City:
Halifax
Zip:
B3H 2Y9
Country:
Canada
Start date:
December 6, 2022
Completion date:
March 15, 2025
Lead sponsor:
Agency:
Nova Scotia Health Authority
Agency class:
Other
Collaborator:
Agency:
Dalhousie University
Agency class:
Other
Source:
Nova Scotia Health Authority
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05508412
